MicroRNA-19a-3p enhances the proliferation and insulin secretion, while it inhibits the apoptosis of pancreatic cells via the inhibition of SOCS3

International Journal of Molecular Medicine

Volumn 38, Issue 5, 2016, Pages 1515-1524

  Li, Yuan ^a   Luo, Tianyou ^a   Wang, Liang ^a   Wu, Jing ^a   Guo, Shixin ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes; Insulin secretion; MicroRNA 19a3p; Pancreatic cells; Proliferation

Indexed keywords

GLUCOSE; INSULIN; MICRORNA; MICRORNA 19A 3P; SMALL INTERFERING RNA; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; MIRN19 MICRORNA, HUMAN; SOCS3 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; UPREGULATION; ANIMAL; BLOOD; CELL LINE; GENE EXPRESSION; GENETICS; METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SECRETION (PROCESS); TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICE; MICRORNAS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SUPPRESSOR OF CYTOKINE SIGNALING 3 PROTEIN;

EID: 84992696188     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2016.2748     Document Type: Article

References (32)

1. Kaul K, Apostolopoulou M and Roden M: Insulin resistance in type 1 diabetes mellitus. Metabolism 64: 1629-1639, 2015.
2. Chatterjee S and Davies MJ: Current management of diabetes mellitus and future directions in care. Postgrad Med J 91: 612-621, 2015.
3. Keane KN, Cruzat VF, Carlessi R, de Bittencourt PI Jr and Newsholme P: Molecular events linking oxidative stress and inflammation to insulin resistance and cell dysfunction. Oxid Med Cell Longev 2015: 181643, 2015.
4. Berge LI and Riise T: Comorbidity between type 2 diabetes and depression in the adult population: Directions of the association and its possible pathophysiological mechanisms. Int J Endocrinol 2015: 164760, 2015.
5. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
6. Bhatia P, Raina S, Chugh J and Sharma S: miRNAs: early prognostic biomarkers for type 2 diabetes mellitus? Biomark Med, 2015.
7. Libânio D, Dinis-Ribeiro M and Pimentel-Nunes P: Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions. World J Clin Oncol 6: 111-132, 2015.
8. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
9. Croce CM and Calin GA: miRNAs, cancer, and stem cell division. Cell 122: 6-7, 2005.
10. Martinez-Sanchez A, Nguyen-Tu MS and Rutter GA: DiCER inactivation identifies oancreatic cell 'Disallowed' genes targeted by MicroRNAs. Mol Endocrinol 29: 1067-1079, 2015.
11. Latreille M, Herrmanns K, Renwick N, Tuschl T, Malecki MT, McCarthy MI, Owen KR, Rülicke T and Stoffel M: miR375 gene dosage in pancreatic cells: Implications for regulation of cell mass and biomarker development. J Mol Med Berl 93: 1159-1169, 2015.
12. Jacovetti C, Matkovich SJ, Rodriguez-Trejo A, Guay C and Regazzi R: Postnatal cell maturation is associated with islet-specific microRNA changes induced by nutrient shifts at weaning. Nat Commun 6: 8084, 2015.
13. Al-Kafaji G, Al-Mahroos G, Alsayed NA, Hasan ZA, Nawaz S and Bakhiet M: Peripheral blood microRNA-15a is a potential biomarker for type 2 diabetes mellitus and pre-diabetes. Mol Med Rep 12: 7485-7490, 2015.
14. Busch S, Auth E, Scholl F, Huenecke S, Koehl U, Suess B and Steinhilber D: 5-Lipoxygenase is a direct target of miR19a3p and miR125b-5p. J Immunol 194: 1646-1653, 2015.
15. Yang J, Zhang Z, Chen C, Liu Y, Si Q, Chuang TH, Li N, GomezCabrero A, Reisfeld RA, Xiang R and Luo Y: MicroRNA-19a3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene. Oncogene 33: 3014-3023, 2014.
16. Zhi F, Shao N, Wang R, Deng D, Xue L, Wang Q, Zhang Y, Shi Y, Xia X, Wang S, et al: Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma. Neuro Oncol 17: 383-391, 2015.
17. Ibarrola-Villava M, Llorca-Cardeñosa MJ, Tarazona N, Mongort C, Fleitas T, Perez-Fidalgo JA, Roselló S, Navarro S, Ribas G and Cervantes A: Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer. Oncotarget 6: 26935-26945, 2015.
18. Balci S, Ayaz L, Gorur A, Yildirim Yaroglu H, Akbayir S, Dogruer Unal N, Bulut B, Tursen U and Tamer L: microRNA profiling for early detection of nonmelanoma skin cancer. Clin Exp Dermatol 41: 346-351, 2016.
19. Zheng G, Du L, Yang X, Zhang X, Wang L, Yang Y, Li J and Wang C: Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma. Br J Cancer 111: 1985-1992, 2014.
20. Zhu Y, Tian F, Li H, Zhou Y, Lu J and Ge Q: Profiling maternal plasma microRNA expression in early pregnancy to predict gestational diabetes mellitus. Int J Gynaecol Obstet 130: 49-53, 2015.
21. Dou L, Meng X, Sui X, Wang S, Shen T, Huang X, Guo J, Fang W, Man Y, Xi J and Li J: miR-19a regulates PTEN expression to mediate glycogen synthesis in hepatocytes. Sci Rep 5: 11602, 2015.
22. Chakraborty C, George Priya Doss C and Bandyopadhyay S: miRNAs in insulin resistance and diabetes-associated pancreatic cancer: The 'minute and miracle' molecule moving as a monitor in the 'genomic galaxy'. Curr Drug Targets 14: 1110-1117, 2013.
23. Wang X, Wang L, Mo Q, Jia A, Dong Y and Wang G: A positive feedback loop of p53/miR-19/TP53INP1 modulates pancreatic cancer cell proliferation and apoptosis. Oncol Rep 35: 518-523, 2016.
24. Tan Y, Yin H, Zhang H, Fang J, Zheng W, Li D, Li Y, Cao W, Sun C, Liang Y, et al: Sp1-driven up-regulation of miR-19a decreases RHOB and promotes pancreatic cancer. Oncotarget 6: 17391-17403, 2015.
25. Zheng Y, Wang Z, Tu Y, Shen H, Dai Z, Lin J and Zhou Z: miR101a and miR30b contribute to inflammatory cytokine-mediated cell dysfunction. Lab Invest 95: 1387-1397, 2015.
26. Leung CM, Chen TW, Li SC, Ho MR, Hu LY, Liu WS, Wu TT, Hsu PC, Chang HT and Tsai KW: MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment. Oncol Rep 31: 2147-2156, 2014.
27. Jiang WL, Zhang YF, Xia QQ, Zhu J, Yu X, Fan T and Wang F: MicroRNA-19a regulates lipopolysaccharide-induced endothelial cell apoptosis through modulation of apoptosis signal-regulating kinase 1 expression. BMC Mol Biol 16: 11, 2015.
28. Kim MH, Kim MS, Kim W, Kang MA, Cacalano NA, Kang SB, Shin YJ and Jeong JH: Suppressor of cytokine signaling (SOCS) genes are silenced by DNA hypermethylation and histone deacetylation and regulate response to radiotherapy in cervical cancer cells. PLoS One 10: e0123133, 2015.
29. Wunderlich CM, Hövelmeyer N and Wunderlich FT: Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity. JAKSTAT 2: e23878, 2013.
30. Krebs DL and Hilton DJ: A new role for SOCS in insulin action. Suppressor of cytokine signaling. Sci STKE 2003: PE6, 2003.
31. Yang Z, Hulver M, McMillan RP, Cai L, Kershaw EE, Yu L, Xue B and Shi H: Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3). PLoS One 7: e47493, 2012.
32. Wang J, Zhou H, Han Y, Liu X, Wang M, Wang X, Yin G, Li X and Xiang M: SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer. J Mol Med Berl 92: 1257-1269, 2014.